CliffBio
small molecule

PAMIDRONATE DISODIUM

PAMIDRONATE DISODIUM

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand namePAMIDRONATE DISODIUM
Active ingredientPAMIDRONATE DISODIUM
Strength30MG/10ML (3MG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2002
Marketing statusDISCN

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.